Overweight (BMI > 25) Clinical Trials

6 recruitingLast updated: May 13, 2026

There are 6 actively recruiting overweight (bmi > 25) clinical trials across 5 countries. Studies span Not Applicable, Early Phase 1, Phase 2. Top locations include Columbia, South Carolina, United States, Girona, Girona, Spain, Leeds, Greater Manchester, United Kingdom. Updated daily from ClinicalTrials.gov.


Overweight (BMI > 25) Trials at a Glance

6 actively recruiting trials for overweight (bmi > 25) are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Columbia, Girona, and Leeds. Lead sponsors running overweight (bmi > 25) studies include AB Biotics, SA, Fondazione Valter Longo, and Leeds Beckett University.

Browse overweight (bmi > 25) trials by phase

Treatments under study

About Overweight (BMI > 25) Clinical Trials

Looking for clinical trials for Overweight (BMI > 25)? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Overweight (BMI > 25) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Overweight (BMI > 25) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 2

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA60 enrolled1 locationNCT07193927
Recruiting
Not Applicable

Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation

Cognitive DysfunctionPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Overweight (BMI > 25)+3 more
Leeds Beckett University70 enrolled1 locationNCT07073781
Recruiting
Not Applicable

Pistachio Snacking and Metabolic Flexibility

Overweight or obeseHealthy ParticipantsObese Patients (BMI ≥ 30 kg/m²)+4 more
University of South Carolina60 enrolled1 locationNCT07340125
Recruiting
Not Applicable

Redox Status and Exercise Training-induced Adaptations

ObesityOverweight (BMI > 25)
University of Thessaly60 enrolled1 locationNCT07196852
Recruiting
Not Applicable

Follow up Study of Varapodio Trial: Effect of Longevity and Fasting Mimicking Diet on Risk Factors Age Correlated and Biomarkers of Aging

fat massObesity (Disorder)Risk Behavior+4 more
Fondazione Valter Longo135 enrolled1 locationNCT07255300
Recruiting
Early Phase 1

L. Acidophilus (Strain TW01) on Gut Health, Body Composition, and Inflammation

Overweight (BMI > 25)Obese, Otherwise Healthy Volunteers
University of Connecticut12 enrolled1 locationNCT06912100